Importance of angiogenesis in reproductive physiology

被引:44
作者
Jaffe, RB [1 ]
机构
[1] Univ Calif San Francisco, Ctr Reprod Sci, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA
关键词
D O I
10.1016/S0146-0005(00)80062-2
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The cyclic angiogenesis that occurs uniquely within the female reproductive tract is critical for normal reproduction. Two families of endothelial cell-specific growth factors and their receptors have been identified in the ovary, uterus, and placenta: vascular endothelial growth factor/vascular permeability factor and the angiopoietings. These appear to have complementary actions on the vasculature and to be involved during intrauterine development as well as in the adult. Within the ovary, a complex cascade of events required for angiogenesis may play a role in follicular maturation and selection as well as in normal corpus luteum function. Aberrant expression of angiogenic factors plays a role in a wide variety of abnormalities in the ovary. In the uterus, angiogenesis is required for endometrial growth and remodeling. Peptide growth factors such as vascular endothelial growth factor may serve as local mediators of the effects of reproductive hormones on the endometrial vasculature. Disease states such as dysfunctional uterine bleeding, endometriosis, and endometrial hyperplasia or cancer may be associated with aberrant uterine angiogenesis. Copyright (C) 2000 by W.B. Saunders Company.
引用
收藏
页码:79 / 81
页数:3
相关论文
共 11 条
[1]   Vascular endothelial growth factor is essential for corpus luteum angiogenesis [J].
Ferrara, N ;
Chen, H ;
Davis-Smyth, T ;
Gerber, HP ;
Nguyen, TN ;
Peers, D ;
Chisholm, V ;
Hillan, KJ ;
Schwall, RH .
NATURE MEDICINE, 1998, 4 (03) :336-340
[2]   MOLECULAR AND BIOLOGICAL PROPERTIES OF THE VASCULAR ENDOTHELIAL GROWTH-FACTOR FAMILY OF PROTEINS [J].
FERRARA, N ;
HOUCK, K ;
JAKEMAN, L ;
LEUNG, DW .
ENDOCRINE REVIEWS, 1992, 13 (01) :18-32
[3]  
Gordon J D, 1995, Obstet Gynecol Surv, V50, P688, DOI 10.1097/00006254-199509000-00024
[4]   Vascular endothelial growth factor localization in human ovary and fallopian tubes: Possible role in reproductive function and ovarian cyst formation [J].
Gordon, JD ;
Mesiano, S ;
Zaloudek, CJ ;
Jaffe, RB .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (01) :353-359
[5]   Role of vascular endothelial cell growth factor in ovarian hyperstimulation syndrome [J].
Levin, ER ;
Rosen, GF ;
Cassidenti, DL ;
Yee, B ;
Meldrum, D ;
Wisot, A ;
Pedram, A .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 102 (11) :1978-1985
[6]   Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis [J].
Maisonpierre, PC ;
Suri, C ;
Jones, PF ;
Bartunkova, S ;
Wiegand, S ;
Radziejewski, C ;
Compton, D ;
McClain, J ;
Aldrich, TH ;
Papadopoulos, N ;
Daly, TJ ;
Davis, S ;
Sato, TN ;
Yancopoulos, GD .
SCIENCE, 1997, 277 (5322) :55-60
[7]   Role of vascular endothelial growth factor in ovarian cancer -: Inhibition of ascites formation by immunoneutralization [J].
Mesiano, S ;
Ferrara, N ;
Jaffe, RB .
AMERICAN JOURNAL OF PATHOLOGY, 1998, 153 (04) :1249-1256
[8]   Corticotropin regulates vascular endothelial growth factor expression in human fetal adrenal cortical cells [J].
Shifren, JL ;
Mesiano, S ;
Taylor, RN ;
Ferrara, N ;
Jaffe, RB .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (04) :1342-1347
[9]   IN THE HUMAN FETUS, VASCULAR ENDOTHELIAL GROWTH-FACTOR IS EXPRESSED IN EPITHELIAL-CELLS AND MYOCYTES, BUT NOT VASCULAR ENDOTHELIUM - IMPLICATIONS FOR MODE OF ACTION [J].
SHIFREN, JL ;
DOLDI, N ;
FERRARA, N ;
MESIANO, S ;
JAFFE, RB .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (01) :316-322
[10]   Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: Implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis [J].
Shifren, JL ;
Tseng, JF ;
Zaloudek, CJ ;
Ryan, IP ;
Meng, YG ;
Ferrara, N ;
Jaffe, RB ;
Taylor, RN .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (08) :3112-3118